Carney-Stratakis syndrome: genes and variants

Explore variant evidence for Carney-Stratakis syndrome across 3 analyzed proteins (SDHD, SDHB, SDHC). Linked ClinVar records include 20 pathogenic or likely pathogenic variants, 176 variants of uncertain significance and 18 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Carney-Stratakis syndrome

ClinVar pathogenic and likely pathogenic variants linked to Carney-Stratakis syndrome

VariantPositionProtein partClinical label
SDHD H102R102TransmembranePathogenic / likely pathogenic (★★)
SDHC R72C72TransmembranePathogenic / likely pathogenic (★★)
SDHD M1I1Pathogenic / likely pathogenic (★★)
SDHD H102N102TransmembranePathogenic / likely pathogenic (★★)
SDHD H102L102TransmembranePathogenic / likely pathogenic (★★)
SDHB I127S1272Fe-2S ferredoxin-typePathogenic / likely pathogenic (★★)
SDHB C192R1924Fe-4S ferredoxin-typePathogenic / likely pathogenic (★★)
SDHB P197S1974Fe-4S ferredoxin-typePathogenic / likely pathogenic (★★)
SDHC R72G72TransmembranePathogenic / likely pathogenic (★★)
SDHB R230H230Pathogenic / likely pathogenic (★★)
SDHB R242H242Pathogenic / likely pathogenic (★★)
SDHD M1V1Pathogenic / likely pathogenic (★★)
SDHD G106D106TransmembranePathogenic / likely pathogenic (★★)
SDHD G106V106TransmembranePathogenic / likely pathogenic (★★)
SDHB W200C2004Fe-4S ferredoxin-typePathogenic / likely pathogenic (★★)
SDHB V140F140Pathogenic / likely pathogenic (★★)
SDHD P81L81TransmembranePathogenic / likely pathogenic (★★)
SDHD G138R138TransmembranePathogenic / likely pathogenic (★★)
SDHD M1T1Pathogenic / likely pathogenic (★)
SDHD L139R139TransmembranePathogenic / likely pathogenic (★)

Uncertain variants prioritized for review in Carney-Stratakis syndrome

VariantPositionProtein partClinical labelEvidence
SDHD G138E138TransmembraneConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; G138R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97

Which prediction tools work for Carney-Stratakis syndrome

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Carney-Stratakis syndrome

Frequently asked questions

Which genes have records linked to Carney-Stratakis syndrome?

This view contains 3 analyzed proteins: SDHD, SDHB, SDHC. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 20 pathogenic or likely pathogenic variants, 176 variants of uncertain significance and 18 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 239 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center